Display options
Cite
Morsy MA. Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian J Pharmacol. 2011;43(6):652-5doi: 10.4103/0253-7613.89820.
Morsy, M. A. (2011). Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian journal of pharmacology, 43(6), 652-5. https://doi.org/10.4103/0253-7613.89820
Morsy, M A. "Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats." Indian journal of pharmacology vol. 43,6 (2011): 652-5. doi: https://doi.org/10.4103/0253-7613.89820
Morsy MA. Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats. Indian J Pharmacol. 2011 Nov;43(6):652-5. doi: 10.4103/0253-7613.89820. PMID: 22144768; PMCID: PMC3229779.
Copy Download .nbib Format: NLM
Share it on

Indian J Pharmacol. 2011 Nov;43(6):652-5. doi: 10.4103/0253-7613.89820.

Protective effect of lisinopril on hepatic ischemia/reperfusion injury in rats.

Indian journal of pharmacology

M A Morsy

Affiliations

  1. Department of Pharmacology, Faculty of Medicine, El-Minia University, El-Minia, Egypt.

PMID: 22144768 PMCID: PMC3229779 DOI: 10.4103/0253-7613.89820

Abstract

OBJECTIVE: Ischemia/reperfusion (I/R) injury plays a key role in the pathogenesis of hepatic failure in several clinical settings such as liver resection or transplantation. Lisinopril, a widely prescribed drug for various cardiovascular conditions, has been reported to have diverse pharmacological properties. The aim of this study, therefore, was to evaluate a potential protective effect of lisinopril on hepatic I/R injury in rats.

MATERIALS AND METHODS: In anesthetized rats, partial hepatic ischemia was applied for one hour followed by two hours reperfusion. Biochemical analysis of serum and hepatic tissue was done. Hepatic tissue was also subjected to electron microscopy.

RESULTS: Pre-ischemic treatment with lisinopril (10 mg/kg) exerted protection against I/R-induced hepatocellular injury as evident by significant decrease in serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), and total bilirubin levels, along with hepatic lipid peroxidation, expressed as malondialdehyde content, with a concurrent increase in hepatic nitric oxide content as compared to I/R group. The electron microscopic examination indicated that lisinopril can effectively protect against hepatic I/R injury.

CONCLUSION: Lisinopril provides a protection against hepatic I/R injury in rats. The protective effect is associated with reduction of oxidative stress-induced lipid peroxidation level and enhancement of nitric oxide availability.

Keywords: Ischemia/reperfusion; lisinopril; liver

References

  1. Biochem Pharmacol. 2001 Aug 15;62(4):509-16 - PubMed
  2. Clin Exp Pharmacol Physiol. 2008 Feb;35(2):159-67 - PubMed
  3. Am J Physiol Gastrointest Liver Physiol. 2003 Jan;284(1):G15-26 - PubMed
  4. Transplantation. 2008 Jan 27;85(2):264-9 - PubMed
  5. Hepatobiliary Pancreat Dis Int. 2006 Nov;5(4):574-9 - PubMed
  6. Am J Health Syst Pharm. 2000 Oct 1;57 Suppl 1:S3-7 - PubMed
  7. Hepatology. 2004 Jun;39(6):1533-43 - PubMed
  8. Planta Med. 2009 Oct;75(12):1286-92 - PubMed
  9. Arch Biochem Biophys. 2009 Apr 15;484(2):232-7 - PubMed
  10. Eur J Clin Invest. 2008 Nov;38(11):820-6 - PubMed
  11. Transplantation. 2001 Jan 27;71(2):193-8 - PubMed
  12. Transplantation. 2004 Mar 15;77(5):748-50 - PubMed
  13. Methods Enzymol. 1978;52:302-10 - PubMed
  14. Anal Biochem. 2002 Jul 1;306(1):79-82 - PubMed
  15. Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H3057-64 - PubMed
  16. Eicosanoids. 1992;5 Suppl:S60-2 - PubMed
  17. J Clin Invest. 1993 Feb;91(2):456-64 - PubMed
  18. N Engl J Med. 1985 Jan 17;312(3):159-63 - PubMed
  19. Mediators Inflamm. 2008;2008:305087 - PubMed
  20. Life Sci. 2006 Jun 6;79(2):121-9 - PubMed
  21. J Am Coll Surg. 2001 Sep;193(3):264-71 - PubMed
  22. Clin Transplant. 1997 Feb;11(1):60-5 - PubMed
  23. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S212-4 - PubMed
  24. Mol Cell Biochem. 2009 Jan;320(1-2):149-62 - PubMed
  25. Am J Physiol. 1993 May;264(5 Pt 2):H1493-7 - PubMed

Publication Types